Versican: A Dynamic Regulator of the Extracellular Matrix
Authors:
Open Access
- 10 September 2020
- journal article
- review article
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 68 (11) , 763-775
Abstract
Versican is a large chondroitin sulfate/dermatan sulfate proteoglycan belonging to the aggrecan/lectican family. In adults, this proteoglycan serves as a structural macromolecule of the extracellular matrix in the brain and large blood vessels. In contrast, versican is transiently expressed at high levels during development and under pathological conditions when the extracellular matrix dramatically changes, including in the inflammation and repair process. There are many reports showing the upregulation of versican in cancer, which correlates with cancer aggressiveness. Versican has four classical splice variants, and all the variants contain G1 and G3 domains at N- and C-termini, respectively. There are two glycosaminoglycan attachment domains CSα and CSβ. The largest V0 variant contains both CSα and CSβ, V1 contains CSβ, V2 contains CSα, and the shortest G3 variant has neither of them. Versican degradation is initiated by cleavage at a site in the CSβ domain by ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) proteinases. The N-terminal fragment containing the G1 domain has been reported to exert various biological functions, although its mechanisms of action have not yet been elucidated. In this review, we describe the role of versican in inflammation and cancer and also address the biological function of versikine.Keywords
Funding Information
- Japan Society for the Promotion of Science (18H02646)
- Japan Society for the Promotion of Science (25293096)
- AIKEIKAI Foundation
This publication has 100 references indexed in Scilit:
- Deletion of miR-126a Promotes Hepatic Aging and Inflammation in a Mouse Model of CholestasisMolecular Therapy Nucleic Acids, 2019
- ADAMTS proteins in human disordersMatrix Biology, 2018
- RETRACTED ARTICLE: LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancerJournal of Experimental & Clinical Cancer Research, 2018
- G1 Domain of Versican Regulates Hyaluronan Organization and the Phenotype of Cultured Human Dermal FibroblastsJournal of Histochemistry & Cytochemistry, 2016
- The Role of the Fibroblast in Inflammatory Upper Airway ConditionsThe American Journal of Pathology, 2016
- Versican is a potential therapeutic target in docetaxel-resistant prostate cancerOncoscience, 2015
- Biosynthesis and function of chondroitin sulfateBiochimica et Biophysica Acta (BBA) - General Subjects, 2013
- Versican G3 Promotes Mouse Mammary Tumor Cell Growth, Migration, and Metastasis by Influencing EGF Receptor SignalingPLOS ONE, 2010
- The sensitivity of versican from rabbit lung to gelatinase A (MMP‐2) and B (MMP‐9) and its involvement in the development of hydraulic lung edemaFEBS Letters, 1999
- Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro.1996